semaglutide and menopause Embracing Change: The Benefits of for Women in The Modern Menopause Solution for

Future perspectives and outstanding questions Despite substantial progress, several unmet needs and key questions require investigation to fully realize the therapeutic potential of GLP-1-based therapies in MASLD/MASH

Diabetes Care 17(10):11001109

Eli Lilly, a competitor of Novo Nordisk, is also manufacturing its version of a GLP-1 pill, orforglipron, which is also expected to be approved soon by the FDA.

Current evidence does not show reversal of established neuropathy

About Havas Health Network: Havas Health Network unites Havas Life, Havas Lynx, and Jacques, all wholly owned health and communications networks, with the consumer health businesses and practices of Havas Creative Network

This has guided the strategy of beginning at a lower dose and stepping up slowly, which mirrors the approach used for other drugs in the same family, such as semaglutide and Tirzepatide